Mark Jeffrey DeLong - 11 Feb 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Issuer symbol
APLS
Transactions as of
11 Feb 2025
Net transactions value
-$10,360
Form type
4
Filing time
12 Feb 2025, 13:59:21 UTC
Previous filing
30 Jan 2025
Next filing
11 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $10,360 -363 -0.43% $28.54 83,945 11 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025